Dr. Darien Sutton and Dr. Stephanie Widmer discuss new studies, which found GLP-1 weight loss drugs beneficial in fighting ...

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief executive officer Michele Buck told analysts in a conference call on fiscal 2024 ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

Researchers from the University of Copenhagen have discovered a new weight loss drug target that works without causing nausea ...

About 1 in 8 U.S. adults have taken Ozempic or similar medications used to treat Type 2 diabetes and obesity. While these ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication that the market for GLP-1 drugs could likely be ... Novo and Lilly also ...